AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
Regulatory clearances achieved that enable integration of the plato™ platform into Fabry FAB-201 and Gaucher GAU-201 clinical trials in the…
Pharmaceuticals, Biotechnology and Life Sciences
Regulatory clearances achieved that enable integration of the plato™ platform into Fabry FAB-201 and Gaucher GAU-201 clinical trials in the…
Regulatory clearances achieved that enable integration of the plato™ platform into Fabry FAB-201 and Gaucher GAU-201 clinical trials in the…
NEW YORK–(BUSINESS WIRE)–Schrödinger today announced that the Company will be presenting on its advanced computational platform, which integrates physics-based molecular…
Company Announces Confirmed Meetings with the U.S. Food and Drug Administration in May and June 2019 to Review Registration Strategy…
Company Announces Confirmed Meetings with the U.S. Food and Drug Administration in May and June 2019 to Review Registration Strategy…
– ElevateBio to leverage its fully integrated, company building bench-to-bedside capabilities exclusively focused on cell and gene therapies – ElevateBio’s…
Food allergy has been essentially highly debatable for decades in atopicdermatitis, with some common food, including milk, egg, and soy. Thereis a lot of literature which provides evidence that common foodexacerbate atopic dermatitis.
Innovus Pharma’s partner Lavasta gets approval to sell Zestra and Zestra Glide in that Algeria
Exelixiswill receive an associated $20 million milestone payment from DaiichiSankyo under the terms of the companies’ collaboration agreement.
Himalaya Drug Company to launch new state-of-the-art Global Research Centre in Dubai DUBAI, United Arab Emirates–(BUSINESS WIRE)–Dubai Science Park (DSP),…